Literature DB >> 9219389

Opium revisited: a brief review of its nature, composition, non-medical use and relative risks.

H Kalant1.   

Abstract

Unlike the pure opioids such as morphine and heroin, opium is a complex and variable mixture of substances reflecting differences in both the starting material and the traditional practices of the regions in which it is produced. Analytical methods have improved greatly in recent years, to the point that the source of a preparation can often be identified by its opioid content and its impurities. Daily amounts used, both by smoking and by mouth, vary widely from less than a gram to 30 g, equivalent to 75-3000 mg of morphine. The effects of opium are essentially those of morphine but unexpected toxicities, such as oesophageal cancer associated with "dross opium" and polyneuropathy due to deliberate addition of arsenic, are problems in some specific regions. Prevalence of use in different areas and countries is governed by the same factors of ease of availability, price and social acceptance that apply to the use of alcohol and other drugs in western countries. The risk of addiction to opium smoking appears to be somewhat less than to parenteral use of heroin, but appreciably greater than to alcohol. Even in countries where its use is traditional, opium smoking carries substantial risks of harm to health and social functioning.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219389

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  23 in total

1.  Cocaine and arsenic-induced Raynaud's phenomenon.

Authors:  B Noël
Journal:  Clin Rheumatol       Date:  2002-08       Impact factor: 2.980

2.  Opportunities in metabolic engineering to facilitate scalable alkaloid production.

Authors:  Effendi Leonard; Weerawat Runguphan; Sarah O'Connor; Kristala Jones Prather
Journal:  Nat Chem Biol       Date:  2009-05       Impact factor: 15.040

Review 3.  Effects of opium consumption on cardiometabolic diseases.

Authors:  Farzad Masoudkabir; Nizal Sarrafzadegan; Mark J Eisenberg
Journal:  Nat Rev Cardiol       Date:  2013-10-22       Impact factor: 32.419

Review 4.  Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

Authors:  Adeleke D Adewumi; Christine E Staatz; Samantha A Hollingworth; Jason P Connor; Rosa Alati
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

5.  Effect of opium use on short-term outcome in patients undergoing coronary artery bypass surgery.

Authors:  Nasser Safaii; Babak Kazemi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-02-13

Review 6.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

Review 7.  The neurobiology of opiate motivation.

Authors:  Ryan Ting-A-Kee; Derek van der Kooy
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

8.  Effects of opium addiction on bleeding after coronary artery bypass graft surgery: report from Iran.

Authors:  Mohammad Hassan Nemati; Behrooz Astaneh; Gholamreza Safaee Ardekani
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-09-22

9.  Opium use and risk of mortality from digestive diseases: a prospective cohort study.

Authors:  Masoud M Malekzadeh; Hooman Khademi; Akram Pourshams; Arash Etemadi; Hossein Poustchi; Mohammad Bagheri; Masoud Khoshnia; Amir Ali Sohrabpour; Ali Aliasgari; Elham Jafari; Farhad Islami; Shahryar Semnani; Christian C Abnet; Paul D P Pharoah; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Reza Malekzadeh; Farin Kamangar
Journal:  Am J Gastroenterol       Date:  2013-10-22       Impact factor: 10.864

10.  Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study.

Authors:  Mahdi Nalini; Masoud Khoshnia; Farin Kamangar; Maryam Sharafkhah; Hossein Poustchi; Akram Pourshams; Gholamreza Roshandel; Samad Gharavi; Mahdi Zahedi; Alireza Norouzi; Masoud Sotoudeh; Arash Nikmanesh; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh; Arash Etemadi
Journal:  Int J Epidemiol       Date:  2021-03-03       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.